Stock Track | Humana Soars 5.11% Pre-market on Strong Q2 Results and Raised 2025 Guidance

Stock Track
07/30

Humana Inc. (HUM) shares surged 5.11% in pre-market trading on Wednesday following the release of its impressive second-quarter 2025 financial results and upgraded full-year guidance. The health insurance giant demonstrated its ability to navigate the challenging healthcare landscape while delivering strong performance.

The company reported adjusted earnings per share (EPS) of $6.27 for Q2, surpassing analysts' expectations of $5.92. Revenue for the quarter reached $32.39 billion, also beating the estimated $31.89 billion. Notably, Humana's medical cost ratio came in at 89.7%, aligning with expectations and indicating effective management of healthcare costs.

Boosting investor confidence, Humana raised its full-year 2025 adjusted EPS guidance to approximately $17.00, up from the previous estimate of $16.25 and exceeding the consensus forecast of $16.38. The company also increased its revenue guidance to at least $128 billion, up from the previous range of $126-128 billion. This optimistic outlook, coupled with the strong Q2 performance, reflects Humana's confidence in its Medicare Advantage business and value-based care strategies, driving the pre-market stock surge.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10